Beijing Anlong Biopharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Beijing Anlong Biopharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06839339) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2025-02-18 |
| Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06718816) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2024-12-09 |
| Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06707753) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2023-09-11 |
Track Beijing Anlong Biopharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.